J&J knew of Risperdal's risks to boys, Lawyer says; GSK plans overhaul of consumer health image;

 @FiercePharma: J&J Hid Risks Risperdal Makes Boys' Breasts Grow: Lawyer--Bloomberg. Report | Follow @FiercePharma

> Johnson & Johnson ($JNJ) knew its antispychotic drug Risperdal could cause boys to grow breasts, but hid those risks, a plaintiff's lawyer said in a Texas court. Report

> GlaxoSmithKline ($GSK) plans to reinvent its consumer healthcare division as a high-profile consumer brand, rather than a division of a Big Pharma company. Report

> Bayer plans to set up its new centralized finance and accounting center in Gdansk, which will start operations later this year and reach full strength in 2014. Report

> The European Generic Medicines Association is protesting new pharmacovigilance fees, saying they put a disproportionate burden on makers of copycat drugs. Report

> Cancer Research UK expects the death rate from cancer in the U.K. to drop by 17% between 2010 and 2030 as diagnosis and treatment improve. Report

Medical Device News

 @FierceMedDev: Abbott Labs is launching its dissolvable coronary stent in Europe, Asia and Latin America. Release | Follow @FierceMedDev

 @MarkHFierce: Bad breath bacteria could be a pancreatic cancer clue. More | Follow @MarkHFierce

 @DamianFierce: Frost & Sullivan says devicemakers must adjust to new pricing pressures to stay afloat. More | Follow @DamianFierce

> Analysts: Devicemakers need to adapt to new economic reality. Article

> Apnex Medical snags $10M for apnea device. News

Biotech News

 @FierceBiotech: In case you missed it last week, check out our 2012 Fierce 15 report: Report | BPA 2012 Slideshow | Follow @FierceBiotech

 @JohnCFierce: One of the two nucs Vertex licensed from Alios ($60M/$1.5B) turned out to be a dud. The other one is headed for PhII. Vertex release | Follow @JohnCFierce

 @RyanMFierce: My interview with Daphne Zohar on how Appeering distills smart banter in biotech from the Twitter hose. Story | Follow @RyanMFierce

> New CEO at GenVec slashes jobs but shelters Novartis partnership. News

> Vertex dumps one hep C dud, races ahead with second all-oral hope. Article

> Is CRO giant Quintiles planning a multibillion-dollar IPO? More

> Sanofi to shed 900 workers with fate of R&D complex undecided. Story

Biotech Research News

> Roche, AstraZeneca lung cancer Rx beat Alzheimer's in fruit flies and mice. Article

> Constellation gains $7.5M to advance preclinical blood cancer drug. More

> Roswell Park researchers spot versatile cancer treatment. Story

> Natural killer cells may be key to lung cancer susceptibility. Item

And Finally... Health officials are scouting for cases of an emerging, SARS-like virus that has killed one person in Saudi Arabia and hospitalized another in the U.K. Report

Suggested Articles

AbbVie and Allergan were already jumping through hoops for their merger before a new tax added hundreds of millions to the cost.

Avastin and Herceptin saw U.S. slowdown that's “not very pronounced” after bioisim launched, but Roche execs still warn of "a significant impact.…

Novo Nordisk, which recently completed a wastewater treatment plant for its massive U.S. API site, has made a gift of the $40 million facility.